cGxP.wire https://validator.w3.org/feed/docs/rss2.html Avanos to Be Acquired by AIP in $1.27B Deal GlycoNex Secures PMDA Nod for GNX1021 Phase 1 Trial Revolution Medicines Reports Phase 3 Survival Gain PDAC Neurocrine Shows INGREZZA Persistence Edge in TD Study SynOx Phase 3 Study Shows TGCT Treatment Benefit BioOra and Cincinnati Advance CAR-T Therapy in Leukemia Penumbra Shows Strong Outcomes in STORM-PE Study Akebia Therapeutics Doses First in AKB-9090 Trial Endpoint Clinical Launches Elosity R3 AI Trial Platform Travere Therapeutics Wins FDA Approval for FILSPARI in FSGS Septerna Initiates SEP-479 Phase 1 Hypoparathyroidism Personalis Advances ctDNA Cancer Monitoring with AI Platform Sirtex Medical Reports 100% Tumor Control in DOORwaY90 Enanta Pharma Advances EDP-978 Phase 1 Urticaria Drug GSK Reports Strong ADC Data in Ovarian Cancer Study Telix and Regeneron Partner to Advance Radiopharma Therapies Ocular Therapeutix AXPAXLI Shows Strong Phase 3 AMD Vivatides Therapeutics Raises $54M to Expand RNA Therapies NeoGenomics Advances AI-Driven Oncology Insights at AACR Eli Lilly Reports Breakthrough Phase 3 Jaypirca Results Daiichi Sankyo Secures FDA Priority Review for ADC Therapy Allogene Therapeutics Reports Strong ALPHA3 Trial Data Novo Nordisk Secures EMA Approval for Wegovy Delivery Flexibility ANI Pharma Launches Carbamazepine ER Capsules in US Nxera Pharma Advances Schizophrenia Drug to Phase 2 Regeneron Dupixent EU Approval Expands Pediatric CSU Care Roche Gets CE Mark for Elecsys NfL MS Blood Test AnBogen Therapeutics Showcases ABT-301 Cancer Breakthroughs AbbVie Reports Strong Phase 2 Data in Ovarian Cancer Spyre to Reveal SKYLINE UC Trial Results on April 13 Replimune RP1 Melanoma Drug Faces FDA Rejection Allogene to Reveal ALPHA3 CAR-T Trial Data Soon IDEAYA to Reveal Phase 3 Melanoma Trial Results Soon Imagene AI, Daiichi Sankyo Advance Oncology Biomarkers Telix NDA Accepted for Pixclara Brain Cancer Imaging Johnson & Johnson Showcases TECNIS PureSee IOL Data Insilico Medicine Advances ISM6200 for Cancer Therapy Lupin Launches Dapagliflozin Tablets in U.S. Market FibroBiologics Advances Thymus Organoid Cancer Therapy Sobi Gains Canada Approval for EMPAVELI Kidney Drug Oxford BioTherapeutics, Bristol Myers Squibb Advance T-Cell Therapies Kymera-Gilead Deal Advances CDK2 Cancer Therapy Emergent Expands NARCAN Supply in BC Opioid Program Vedanta Biosciences Advances Microbiome Drugs at ESCMID 2026 Vanda Urges FDA to Reject Extended Drug Review Timelines Jazz Pharmaceuticals Presents Neurology Drug Data at AAN Innovent Showcases Tri-Specific Autoimmune Therapy Data HeartFocus, Inteleos Launch AI Cardiac POCUS Certification Revision Skincare Validates Vitamin C Serum in Clinical Studies DualityBio Advances HER2 ADC Toward China Approval